Crescenta Biosciences, Inc. – Novel Therapeutic Approaches for Treatment of Metabolic Diseases. Crescenta, a start-up biotechnology company is developing a novel small molecule drug discovery platform comprised of chemical libraries and proteomics methods, to create new drugs with unique mechanisms of action.
Eton Bioscience, Inc. – Molecular Tools and Services – Eton develops and provides a repertoire of cutting edge nucleic acid and protein synthesis and sequencing services to the biological research communities of academia and industry to advance their ongoing experiments and investigations.
ZingyGen Inc. – Vaccine Discovery & Immune Therapies for Treatment of Tropical Diseases – ZignyGen, a discovery stage biotechnology company is utilizing a novel technology to develop vaccines and immune therapies for the treatment of chronic inflammatory diseases.
nanoDerm Sciences, Inc. – Targeted Therapeutic Nano Gels for Drug-Delivery – nanoDerm is developing a novel nanoparticle-antibiotic conjugate system for topical treatment of resistant bacterial wound infections, at higher and more consistent doses, while overcoming potential side-effects associated with systemic administration.
MDSeq, Inc. – MDSeq Inc is developing a proprietary molecular diagnostics platform.
Prokaryotics Inc.. – Prokaryotics is an authentic antibacterial discovery organization committed to bringing forth innovative therapeutics to address the problem of multi-drug resistant bacteria and combating the emerging global crisis of antibiotic resistance.